Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
O.N. Diagnostics is a medical technology company that specializes in advanced bone health assessment using its proprietary VirtuOst technology. The company's primary offering is Biomechanical Computed Tomography (BCT) analysis, which utilizes existing clinical CT scans to provide highly accurate measurements of bone strength and density. This technology is FDA-cleared and serves as a powerful tool for diagnosing osteoporosis and assessing fracture risk, often outperforming traditional DXA scans. Beyond clinical diagnostics, O.N. Diagnostics provides specialized bone-analysis services for pharmaceutical companies to support clinical trials for new bone-active drugs. The company is based in Berkeley, California, and was founded by experts in bone biomechanics from the University of California, Berkeley.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on ON Diagnostics.